• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Automata

To add a bio or update company history click update information.

News from Automata

    Automata raises £33m Series C led by Dimension to build the operating layer between physical labs and AI modelsAutomata raises £33m Series C led by Dimension to build the operating layer between physical labs and AI models
    Automata
    29 Jan 2026

    Automata raises £33m Series C led by Dimension to build the operating layer between physical labs and AI models

    Automata builds integrated lab automation systems for life sciences research. Its platform combines robotics, software and data infrastructure to help laboratories run experiments more consistently and at higher throughput.

Automata
  • Life Sciences
  • London, United Kingdom
  • £33m
  • automata.tech
  • Update Information

More venture news

  • Perceptic raises a £9m seed round led by Accel to unify drug discovery and development on a single AI platform
    Perceptic
    28 May 2026

    Perceptic raises a £9m seed round led by Accel to unify drug discovery and development on a single AI platform

    SeedLife Sciences
  • Imperagen secures a £5m seed round led by PXN Ventures to accelerate the process of enzyme engineering
    Imperagen
    21 May 2026

    Imperagen secures a £5m seed round led by PXN Ventures to accelerate the process of enzyme engineering

    SeedLife Sciences
  • Infex Therapeutics secures £4.3m in funding led by Jon Moulton for antimicrobial resistance treatments
    Infex Therapeutic
    12 May 2026

    Infex Therapeutics secures £4.3m in funding led by Jon Moulton for antimicrobial resistance treatments

    EquityLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn